Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial

Cibula, David, Rob, Lukas, Mallmann, Peter · Gynecologic Oncology · 2021